drugset
drugset / Trial / NCT02882711

The UTHealth Ketamine Project

NCT02882711 ↗

Phase 2 Terminated 10 enrolled The University of Texas Health Science Center, Houston
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study is to determine the effectiveness of serial infusions of intravenous (IV) ketamine in adults with treatment resistant depression (TRD).

Timeline

Start
2016-11-07
Primary completion
2017-08-16
Completion
2017-08-16

Outcome

Outcome not reported

Stopped: “Increasing off-label practice of IV ketamine administration for treatment-resistant depression.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous

Indications

bipolar disorder major depressive disorder